Sanofi partners with BIG, EORTC, AFT to study amcenestrant for ER+ breast cancer treatment
Amcenestrant is an oral SERD that antagonises and degrades the estrogen receptor (ER), resulting in inhibition of the ER signaling…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.